Endothelin-2 in Ovarian Follicle Rupture
卵巢卵泡破裂中的内皮素 2
基本信息
- 批准号:7393644
- 负责人:
- 金额:$ 23.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-05-15 至 2011-02-28
- 项目状态:已结题
- 来源:
- 关键词:Animal ModelBQ123Binding SitesBiochemicalBiochemical ProcessClinicalConstriction procedureCountCystDatabasesDevelopmentDiseaseEndothelinEndothelin ReceptorEndothelin Receptor AntagonistEndothelin-2Estrogen Receptor alphaEstrogensExperimental ModelsFailureFemale infertilityGene ExpressionGene Expression ProfilingGenesGenomeGoalsGrowthHormonalImmunohistochemistryIn Situ HybridizationIndividualIndomethacinInfertilityInjection of therapeutic agentIsometric ExerciseKnockout MiceKnowledgeLabelLeadLinkLuteinizing HormoneMammalian OviductsMeasurementMeasuresMediatingMolecularMolecular ProfilingMusNumbersOocytesOvarianOvarian DiseasesOvarian FollicleOvarian TissueOvaryOvulationPTGS2 genePatternPituitary GonadotropinsPoriferaProcessProgesteroneProgesterone ReceptorsProstaglandin ReceptorProstaglandinsRU-486RadioimmunoassayRattusResearch PersonnelResidual stateReverse Transcriptase Polymerase Chain ReactionRoleRuptureSmooth MuscleStructureSymptomsSyndromeSystemTechniquesTheca ExternaTherapeuticTissuesVasoactive Intestinal Peptidecorpus luteumgranulosa cellin vivoinhibitor/antagonistintraovariannovelprogramsreceptorresearch studytezosentantherapeutic target
项目摘要
The goal of the proposed studies is to elucidate the mechanism of endothelin-2 (EDN-2) action in follicle
rupture. The program of ovulation is activated by a surge of luteinizing hormone, which initiates dramatic
changes in molecular, biochemical, and physical aspects of the ovary, eventually leading to rupture of
follicles. However, the factors involved in and the mechanism governing the process of follicle rupture are yet
to be unveiled. Using a gene expression profiling approach, we have identified EDN-2, a potent smooth
muscle constrictor, which is exclusively and transiently expressed in the granulosa cells of periovulatory
follicles immediately prior to ovulation. We found that EDN-2 induces rapid and sustained contraction in the
ovarian tissue, while tezosentan, an endothelin receptor antagonist, released the contraction. These novel
findings led us to hypothesize that EDN-2 directly constricts periovulatory follicles leading to the rupture of
the follicle. Supporting the hypothesis, immunohistochemical analysis identified a well-organized smooth
muscle layer in the theca externa of each follicle, which forms a sponge-like smooth muscle network at the
whole ovarian level. Furthermore, we found that intraovarian injection of tezosentan prior to ovulation
completely blocked follicle rupture. In this study, we will elucidate the mechanism of EDN-2 action in follicle
rupture. We will determine the target tissues of EDN-2 action, the endothelin receptor subtype(s) that
mediates EDN-2 action, and the ovarian concentration of EDN-2. We will also determine the mechanism of
endothelin-2 induced follicular constriction in relation to other ovary-produced vasoconstrice molecules
(VIPs, PACAPs, and prostaglandins). In addition, the functional link of progesterone, estrogen, and
prostaglandin to the follicle rupture in relation to EDN-2 will be explored. The major strength of this proposal
is in the identification of EDN-2 and the ovarian smooth muscle network as the key components of follicle
rupture. The novelty of the proposed experiments is the interdisplinary approachs (genome-wide gene
expression profiling, intraovarian injection, and isometric tension measurement). The proposed studies are
exceptionally important in order to further our understanding of the mechanism of follicle rupture. The
proposed experiments will provide clinical direction in identifying the therapeutic target for the cure of
annovulatory symptoms, one of the leading causes of female infertility.
本研究的目的是阐明内皮素-2 (EDN-2)在卵泡中的作用机制
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHEMYONG JAY KO其他文献
CHEMYONG JAY KO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHEMYONG JAY KO', 18)}}的其他基金
Conversion of ERalpha cells to ERbeta cells in a cell lineage
细胞谱系中 ERalpha 细胞向 ERbeta 细胞的转化
- 批准号:
9756432 - 财政年份:2018
- 资助金额:
$ 23.14万 - 项目类别:
Mechanism of Periovulatory Leukocyte Infiltration into the Ovary
排卵期白细胞浸润卵巢的机制
- 批准号:
8609429 - 财政年份:
- 资助金额:
$ 23.14万 - 项目类别:
Mechanism of Periovulatory Leukocyte Infiltration into the Ovary
排卵期白细胞浸润卵巢的机制
- 批准号:
9117287 - 财政年份:
- 资助金额:
$ 23.14万 - 项目类别:
相似国自然基金
仿血小板纳米粒联合BQ123通过自放大靶向效应增强肿瘤光热治疗的研究
- 批准号:81671815
- 批准年份:2016
- 资助金额:56.0 万元
- 项目类别:面上项目














{{item.name}}会员




